Interventional Oncology Devices Market, By Product (Embolization Devices, Ablation Devices, and Support Devices), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, and Transcatheter Arterial Embolization/Bland Embolization), By Cancer (Liver Cancer, Lung Cancer, Bone Cancer, and Kidney Cancer), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI399620 | Publish Date: June 2022 | No. of Pages: 167

Global Interventional Oncology Devices Market Overview

Oncology deals with the diagnosis, prevention, treatment of cancer. A physician who works in the field of oncology is called an oncologist. Various ultrasound or radiological methods such as endoscopy, biopsy, X-ray, MRI, CT scanning, PET scanning, and others are used to diagnose cancer. The interventional device is a type of cancer care which is done with minimally invasive procedures, minimal complications, and reduce the risk of infection, shorter hospital stay, lesser pain, and faster recovery time as compared to the conventional open surgeries. The global interventional oncology devices market accounted for US$ 4.2 billion in 2025 and is projected to register a moderate CAGR over the forecast period.

Global Interventional Oncology Devices Market Dynamics

 

Growing incidence and increasing prevalence of cancer

Growing incidence and increasing prevalence of cancer globally among individuals is the major factor driving the growth of the global interventional oncology devices. According to data published by WHO, cancer acts as the second leading cause of death worldwide and accounted for 9.6 million deaths in 2018. Approximately 70% of deaths occur in low- and middle-income countries from cancer. Also, high preference for minimally invasive surgical procedures, favourable reimbursement scenario for interventional oncology treatment in developed countries, availability of government and private funding, and others. These factors are also expected to boost the growth of the global market over the forecast period. However, the lack of clinical pieces of evidence for localized region treatment and increasing financial burden on industry players with a high number of product recalls is restraining the growth of the target market. Nevertheless, increasing merger and acquisitions among the industry players along with product launches are expected to create lucrative growth opportunities for the target market over the forecast period.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Interventional Oncology Devices Market Segmentation

 

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The global interventional oncology devices market is segmented based on the product, procedure, cancer, and region.

Based on the product, the global interventional oncology devices market is segmented into embolization devices, ablation devices, and support devices. Based on procedure, the target market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial radioembolization/selective internal radiation therapy, and transcatheter arterial embolization/bland embolization. Based on cancer, the global is classified into liver cancer, lung cancer, bone cancer, and kidney cancer.

Regional Insights:

On the region, the global interventional oncology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2018, North America accounted for the highest share of the global interventional oncology market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific is expected to be the fastest-growing regional market owing to growing government focus on the healthcare sector and accelerated economic growth of many countries in this region. Additionally, rising incidence & prevalence of cancer; government initiatives towards the development of healthcare facilities, a growing number of middle-class population and their level of disposable income are the factors boosting the growth of the target market. Moreover, the growing ageing population and increasing health insurance penetration in the region are also propelling the growth of the Asia-Pacific interventional oncology market

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Product- Embolization Devices, Ablation Devices, and Support Devices

By Procedure– Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, and Transcatheter Arterial Embolization/Bland Embolization

By Cancer– Liver Cancer, Lung Cancer, Bone Cancer, and Kidney Cancer

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

 

 

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global interventional oncology devices markets report based on Product, Procedure, Cancer and Region.

                                

Global interventional oncology devices markets, By Region:

 

  • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Interventional Oncology Devices Market Key Players

The key players operating the global interventional oncology devices market include AngioDynamics Inc., Becton, Dickinson and Company, Boston Scientific Corporation, BTG PLC, HealthTronics Inc., Medtronic PLC, Sirtex Medical Ltd., Merit Medical Systems Inc., and Terumo Corporation. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. BD is presently the largest shareholder in the target market. In 2018, the company’s contribution was valued to be 23.06% of the global interventional oncology devices market value. However, companies namely Terumo Corporation, Boston Scientific Corporation, and Merit Medical Systems, Inc. are projected to witness impeccable growth in the forecast period. 

Global Interventional Oncology Devices Market Company Profile

  • AngioDynamics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • BTG PLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • HealthTronics Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Medtronic PLC
    •  Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

 

Global Interventional Oncology Devices Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Interventional Oncology Devices Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By Procedure
      • Market Snippet, By Cancer
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Interventional Oncology Devices Market, By Product, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Embolization Devices
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Ablation Devices
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Support Devices
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Interventional Oncology Devices Market, By Procedure, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Thermal Tumor Ablation
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Non-Thermal Tumor Ablation
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Transcatheter Arterial Chemoembolization
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Transcatheter Arterial Embolization/Bland Embolization
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Interventional Oncology Devices Market, By Cancer, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Liver Cancer
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Lung Cancer
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Bone Cancer
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Kidney Cancer
      • Overview
      • Market Interventional Oncology Devices and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Interventional Oncology Devices Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Procedure, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Cancer, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Procedure, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Cancer, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Procedure, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Cancer, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Procedure, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Cancer, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Procedure, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Cancer, 2020 – 2030
      • Market Interventional Oncology Devices and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • AngioDynamics Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Becton, Dickinson and Company
      • Boston Scientific Corporation
      • BTG PLC
      • HealthTronics Inc.
      • Medtronic PLC
      • Sirtex Medical Ltd.
      • Merit Medical Systems Inc.
      • Terumo Corporation
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global interventional oncology devices market is segmented based on the product, procedure, cancer, and region.

Growing incidence and increasing prevalence of cancer globally among individuals is the major factor driving the growth of the global interventional oncology devices.

In 2018, North America accounted for the highest share of the global interventional oncology market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa.

The key players operating the global interventional oncology devices market include AngioDynamics Inc., Becton, Dickinson and Company, Boston Scientific Corporation, BTG PLC, HealthTronics Inc., Medtronic PLC, Sirtex Medical Ltd., Merit Medical Systems Inc., and Terumo Corporation.